250 related articles for article (PubMed ID: 9219519)
1. Identification of phosphopeptide ligands for the Src-homology 2 (SH2) domain of Grb2 by phage display.
Gram H; Schmitz R; Zuber JF; Baumann G
Eur J Biochem; 1997 Jun; 246(3):633-7. PubMed ID: 9219519
[TBL] [Abstract][Full Text] [Related]
2. Potent inhibitory ligands of the GRB2 SH2 domain from recombinant peptide libraries.
Hart CP; Martin JE; Reed MA; Keval AA; Pustelnik MJ; Northrop JP; Patel DV; Grove JR
Cell Signal; 1999 Jun; 11(6):453-64. PubMed ID: 10400318
[TBL] [Abstract][Full Text] [Related]
3. Rapid identification of phosphopeptide ligands for SH2 domains. Screening of peptide libraries by fluorescence-activated bead sorting.
Müller K; Gombert FO; Manning U; Grossmüller F; Graff P; Zaegel H; Zuber JF; Freuler F; Tschopp C; Baumann G
J Biol Chem; 1996 Jul; 271(28):16500-5. PubMed ID: 8663178
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7.
Pero SC; Oligino L; Daly RJ; Soden AL; Liu C; Roller PP; Li P; Krag DN
J Biol Chem; 2002 Apr; 277(14):11918-26. PubMed ID: 11809769
[TBL] [Abstract][Full Text] [Related]
5. Nonphosphorylated peptide ligands for the Grb2 Src homology 2 domain.
Oligino L; Lung FD; Sastry L; Bigelow J; Cao T; Curran M; Burke TR; Wang S; Krag D; Roller PP; King CR
J Biol Chem; 1997 Nov; 272(46):29046-52. PubMed ID: 9360978
[TBL] [Abstract][Full Text] [Related]
6. Functional preference of the constituent amino acid residues in a phage-library-based nonphosphorylated inhibitor of the Grb2-SH2 domain.
Lung FD; Long YQ; Roller PP; King CR; Varady J; Wu XW; Wang S
J Pept Res; 2001 Jun; 57(6):447-54. PubMed ID: 11437948
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for a non-phosphorus-containing cyclic peptide binding to Grb2-SH2 domain with high affinity.
Li P; Zhang M; Peach ML; Zhang X; Liu H; Nicklaus M; Yang D; Roller PP
Biochem Biophys Res Commun; 2003 Aug; 307(4):1038-44. PubMed ID: 12878216
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands.
Rahuel J; García-Echeverría C; Furet P; Strauss A; Caravatti G; Fretz H; Schoepfer J; Gay B
J Mol Biol; 1998 Jun; 279(4):1013-22. PubMed ID: 9642078
[TBL] [Abstract][Full Text] [Related]
10. Changes in structural dynamics of the Grb2 adaptor protein upon binding of phosphotyrosine ligand to its SH2 domain.
de Mol NJ; Catalina MI; Fischer MJ; Broutin I; Maier CS; Heck AJ
Biochim Biophys Acta; 2004 Jul; 1700(1):53-64. PubMed ID: 15210125
[TBL] [Abstract][Full Text] [Related]
11. A screening method of SH2 domain ligands and blockers using a solid phase binding.
Koh WS; Yoon SY; Lee EK; Lee EK; Kwon BM; Kim JW; Han MY
Cancer Lett; 1997 Nov; 120(1):1-7. PubMed ID: 9570379
[TBL] [Abstract][Full Text] [Related]
12. Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.
Bibbins KB; Boeuf H; Varmus HE
Mol Cell Biol; 1993 Dec; 13(12):7278-87. PubMed ID: 7504171
[TBL] [Abstract][Full Text] [Related]
13. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM
Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042
[TBL] [Abstract][Full Text] [Related]
14. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions.
Simon JA; Schreiber SL
Chem Biol; 1995 Jan; 2(1):53-60. PubMed ID: 9383403
[TBL] [Abstract][Full Text] [Related]
15. Structural and biophysical investigation of the interaction of a mutant Grb2 SH2 domain (W121G) with its cognate phosphopeptide.
Papaioannou D; Geibel S; Kunze MB; Kay CW; Waksman G
Protein Sci; 2016 Mar; 25(3):627-37. PubMed ID: 26645482
[TBL] [Abstract][Full Text] [Related]
16. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
[TBL] [Abstract][Full Text] [Related]
17. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
[TBL] [Abstract][Full Text] [Related]
18. The Grb2-mSos1 complex binds phosphopeptides with higher affinity than Grb2.
Chook YM; Gish GD; Kay CM; Pai EF; Pawson T
J Biol Chem; 1996 Nov; 271(48):30472-8. PubMed ID: 8940013
[TBL] [Abstract][Full Text] [Related]
19. Identification of natural ligands for SH2 domains from a phage display cDNA library.
Cochrane D; Webster C; Masih G; McCafferty J
J Mol Biol; 2000 Mar; 297(1):89-97. PubMed ID: 10704309
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation of nicotinic acetylcholine receptor mediates Grb2 binding.
Colledge M; Froehner SC
J Neurosci; 1997 Jul; 17(13):5038-45. PubMed ID: 9185541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]